NETHERLANDS - Thuja et al. in series-A round for FABPulous
Thuja Capital, Health Innovation Fund, Limburg Ventures and NV Industriebank LIOF have co-led an indisclosed investment into biotechnology firm FABPulous, in a first round of institutional funding.
FABPulous was founded in 2008 as a spin off of Maastricht University with start-up capital provided by MeDaVinci Development, which also participated in this latest round.
The company is developing a disposable device thatows for rapid semi-quantitative diagnostic testing in blood or plasma. As a first application, FABPulous will develop a rapid test to aid in the diagnosis of acute myocardial infarction, based on an early biomarker, heart-type fatty acid.
The new financing will enable FABPulous to develop the device and launch its first application as a rapid in vitro diagnostic (IVD) test for myocardial infarction.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








